Journal profile · OPHTHALMOLOGY
Eye and Brain
ISSN 1179-2744 · Dove Medical Press · United Kingdom
Eye and Brain: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 4.3 (journal website); JCR Q1 (journal website); fully open access; APC about USD 3,940; median 117 days to acceptance (24 articles, last 24 months); acceptance rate 19% (journal website); 13 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Eye and Brain is published by Dove Medical Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Glaucoma and retinal disorders, Visual perception and processing mechanisms and Retinal Diseases and Treatments, together about 27.2% of its articles. Its main subfields are Ophthalmology. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Dr Rustum Karanjia Eye and Brain is an international, peer-reviewed, open access journal focusing on cutting-edge laboratory findings and expert reviews in the field of visual science and neuro-ophthalmology. The journal’s unique focus is the link between two well-known visual centers, the eye and the brain, with an emphasis on the importance of such connections as well as on the eye as a window for neurodegenerative diseases. All aspects of basic research on the visual system are addressed within the journal as well as significant future directions in vision research and therapeutic measures. This unique journal focuses on neurological aspects of vision – both physiological and pathological. The scope of the journal spans from the cornea to the associational visual cortex and all the visual centers in between. Topics range from basic biological mechanisms to therapeutic treatment, from simple organisms to humans, and utilizing techniques from molecular biology to behavior. The journal especially welcomes primary research articles or review papers that make the connection between the eye and the brain. Eye and Brain will no longer consider meta-analyses or bibliometric analysis studies for publication. Any case reports or case series submitted to Eye and Brain will automatically be diverted to the International Medical Case Reports Journal (Journal metric data for this journal can be accessed here). Specific areas covered in the journal include: Physiology and pathophysiology of visual centers Eye movement disorders and strabismus Cellular, biochemical, and molecular features of the visual system Structural and functional organization of the eye and of the visual cortex Metabolic demands of the visual system Diseases and disorders with neuro-ophthalmic manifestations Experimental neuro-ophthalmology and visual system pathology Visual dysfunction in neurodegenerative disease The journal welcomes submissions of original research, review papers, evaluations, guidelines, expert opinion and commentary and extended reports. Updated 16 July 2025
From the journal's Aims & Scope
Research area (LetPub): OPHTHALMOLOGY
Editor-in-chief Rustum KaranjiaPublisher website
Editorial board by country: none in mainland China; most named United States 28, Canada 6, India 3, Italy 2, Spain 1 (41 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Glaucoma and retinal disordersMedicine12.1%
- Visual perception and processing mechanismsNeuroscience9.1%
- Retinal Diseases and TreatmentsMedicine6%
- Retinal Development and DisordersBiochemistry, Genetics and Molecular Biology5.7%
- Retinopathy of Prematurity StudiesMedicine5.7%
- Ophthalmology and Visual Impairment StudiesMedicine5%
- Retinal and Optic ConditionsMedicine4.7%
- Multiple Sclerosis Research StudiesMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Ophthalmology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Ophthalmology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q1 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SJR, CiteScore, Impact FactorPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 4.3Publisher website ·
- 5-year impact factor (publisher)
- 4.6Publisher website ·
- CiteScore 2026-06
- 4.6LetPub ·
- CiteScore (publisher) 2025
- 1.58Publisher website ·
- SJR 2026-06
- 0.79LetPub ·
- SNIP 2026-06
- 1.58LetPub ·
- h-index
- 40OpenAlex ·
- i10-index
- 103OpenAlex ·
- 2-year mean citedness
- 4.06OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 13LetPub ·
- Downloads per year (publisher)
- 36,568Publisher website ·
Articles by year OpenAlex count · 219 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 8 | 8 | 2 |
| 2025 | 13 | 13 | 37 |
| 2024 | 12 | 12 | 95 |
| 2023 | 13 | 13 | 171 |
| 2022 | 10 | 10 | 104 |
| 2021 | 23 | 23 | 488 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
117 daysMedian, submission to acceptance · P25–P75 95 days – 157 days
- Acceptance to online
- median 14 days (24 articles)
- Submission to online
- median 146 days
- Sample
- 24 articles with submission and acceptance dates (28 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Acceptance rate (publisher)
- 19%Publisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,940 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,320 | — | — | |
| LetPub | USD 3,300 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
- reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Policy excerpts from the journal's websitePublication ethics
- Publication ethics
Member of and subscribes to the principles of the Committee on Publication Ethics (COPE). Model summary
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dove Medical Press
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1179-2744
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Eye and Brain
What CAS zone is Eye and Brain in?
In the 2025 upgraded edition of the CAS Journal Ranking, Eye and Brain is in Zone 4 of Medicine, and in Zone 3 of the minor category Ophthalmology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Eye and Brain?
The journal's website gives an impact factor of 4.3 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 4.6, h-index 40.
How long does peer review take at Eye and Brain?
Based on the dates recorded on 24 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 117 days (interquartile range 95–157 days); authors report an average review time of about 16 weeks; the journal's website gives an acceptance rate of 19%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Eye and Brain in?
The journal's website gives JCR Q1 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Where are the editorial board members of Eye and Brain based?
Of the 41 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (28), Canada (6) and India (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Eye and Brain?
According to LetPub and DOAJ records, Eye and Brain is indexed in ESCI, Scopus and DOAJ.
Is Eye and Brain open access, and what is the APC?
Eye and Brain is a fully open-access journal. APC about USD 3,940.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-28). Last updated: .